A blog about the intersection of medicine and business, produced by the members of the Medical Consumerism seminar at the University of Minnesota.
Thursday, March 03, 2011
Do dying research subjects know what they've signed up for?
Why do dying cancer patients sign up for clinical trials designed only to test the toxicity of a drug? The answer is not what you'd hope. Read about it in the New York Times.
No comments:
Post a Comment